Craig Jaffe

Summary

Affiliation: University of Washington
Country: USA

Publications

  1. ncbi request reprint A comparison of methamphetamine-dependent inpatients childhood attention deficit hyperactivity disorder symptomatology
    Craig Jaffe
    Department of Psychiatry and Behavioral Sciences, University of Washington, 12013 Pinehurst Way NE, Seattle, WA 98125, USA
    J Addict Dis 24:133-52. 2005
  2. ncbi request reprint An open-label pilot study of risperidone in the treatment of methamphetamine dependence
    Charles W Meredith
    Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA
    J Psychoactive Drugs 39:167-72. 2007
  3. ncbi request reprint Open trial of injectable risperidone for methamphetamine dependence
    Charles W Meredith
    From the Mental Health Service CWM, JPR, CAM, EVY, AK, LCF, Amt, and AJS, Center of Excellence in Substance Abuse Treatment and Education CAM, LCF, and AJS, VA Puget Sound Health Care System and Department of Psychiatry and Behavioral Sciences CWM, CJ, MC, LCF, Amt, and AJS, University of Washington, Seattle, WA
    J Addict Med 3:55-65. 2009
  4. ncbi request reprint The content and clinical utility of psychiatric advance directives
    Debra S Srebnik
    Department of Psychiatry and Behavioral Sciences, University of Washington, 325 Ninth Avenue, Seattle, WA 98104, USA
    Psychiatr Serv 56:592-8. 2005
  5. ncbi request reprint Single dose of 24 milligrams of buprenorphine for heroin detoxification: an open-label study of five inpatients
    Kathleen Ang-Lee
    Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington 98195 6560, USA
    J Psychoactive Drugs 38:505-12. 2006
  6. ncbi request reprint Implications of chronic methamphetamine use: a literature review
    Charles W Meredith
    Department of Psychiatry and Behavioral Sciences, University of Washington, and VA Puget Sound Health Care System S 116 ATC, 1160 S Columbian Way, Seattle, WA 98108, USA
    Harv Rev Psychiatry 13:141-54. 2005

Collaborators

Detail Information

Publications6

  1. ncbi request reprint A comparison of methamphetamine-dependent inpatients childhood attention deficit hyperactivity disorder symptomatology
    Craig Jaffe
    Department of Psychiatry and Behavioral Sciences, University of Washington, 12013 Pinehurst Way NE, Seattle, WA 98125, USA
    J Addict Dis 24:133-52. 2005
    ..All participants demonstrated significant reductions in psychiatric symptoms with abstinence. Methamphetamine-dependent individuals with ADHD symptoms are common and pose a significant treatment challenge...
  2. ncbi request reprint An open-label pilot study of risperidone in the treatment of methamphetamine dependence
    Charles W Meredith
    Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA
    J Psychoactive Drugs 39:167-72. 2007
    ..0 (SD = 8.4) to 51.8 (SD = 8.3; t = 2.7, p <.05), and positive symptom distress declined from a mean of 52.8 (SD =8.0) to 41.7 (SD = 8.6; t= 3.0, p <.05). Risperidone was well tolerated and associated with decreased MA use...
  3. ncbi request reprint Open trial of injectable risperidone for methamphetamine dependence
    Charles W Meredith
    From the Mental Health Service CWM, JPR, CAM, EVY, AK, LCF, Amt, and AJS, Center of Excellence in Substance Abuse Treatment and Education CAM, LCF, and AJS, VA Puget Sound Health Care System and Department of Psychiatry and Behavioral Sciences CWM, CJ, MC, LCF, Amt, and AJS, University of Washington, Seattle, WA
    J Addict Med 3:55-65. 2009
    ..However, these results are limited by the use of an open trial design with a high dropout rate. Risperidone deserves further study in controlled trials as a pharmacotherapy for MA dependence...
  4. ncbi request reprint The content and clinical utility of psychiatric advance directives
    Debra S Srebnik
    Department of Psychiatry and Behavioral Sciences, University of Washington, 325 Ninth Avenue, Seattle, WA 98104, USA
    Psychiatr Serv 56:592-8. 2005
    ..This paper provides the first systematic examination of the content and clinical utility of psychiatric advance directives, which are documents that specify treatment preferences in advance of periods of compromised decision making...
  5. ncbi request reprint Single dose of 24 milligrams of buprenorphine for heroin detoxification: an open-label study of five inpatients
    Kathleen Ang-Lee
    Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine, Seattle, Washington 98195 6560, USA
    J Psychoactive Drugs 38:505-12. 2006
    ..Use of ancillary medications was minimal. This study suggests that a single high dose of buprenorphine can be used safely and effectively for inpatient detoxification...
  6. ncbi request reprint Implications of chronic methamphetamine use: a literature review
    Charles W Meredith
    Department of Psychiatry and Behavioral Sciences, University of Washington, and VA Puget Sound Health Care System S 116 ATC, 1160 S Columbian Way, Seattle, WA 98108, USA
    Harv Rev Psychiatry 13:141-54. 2005
    ..Atypical antipsychotics may have some promise in this regard...